Mantle Cell Lymphoma Life Expectancy Depends On Various Factors

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of non-Hodgkin's lymphoma, and it generally does not have a good prognosis. It is a very rare disease, affecting no more than about 4,000 people (generally men and generally older than 60) in the US every year. This is the equivalent of about 5% of all non-Hodgkin's lymphoma diagnoses made annually.

Mantle cell lymphoma is poorly understood by the medical community, largely because it was only recognized as a legitimately unique B-cell NHL subtype twenty years ago. In that time, a wide variety of treatments—including chemotherapy, radiotherapy, stem cell transplantations, and immunotherapy—have been applied to patients with mantle cell lymphoma, with varying results, none of them especially convincing or leading to much enthusiasm in the research community.

Life Expectancy

The life expectancy for any patient receiving a diagnosis of mantle cell lymphoma will vary widely, depending on various factors ranging from age and health status, to stage of the disease at diagnosis and whether the patient has so-called B symptoms or not. The problem is that in many instances, and following virtually all modes of treatment, the disease is extremely prone to returning; relapse in is very common, and when relapse occurs, the relapsed disease has all too commonly become chemo-resistant as well.

Thus, while it is impossible to say how long any one individual patient will survive following a diagnosis of mantle cell lmyphoma, currently the life expectancy is cited as being in the range of four to five years following diagosis, according to researchers at the John Theurer Cancer Center in Hackensack, New Jersey.

Sources

Related Reading

Photo: Pexels

Mantle Cell Lymphoma
w00001
web
chnm3: 
lin

More Articles

More Articles

This entry looks at what is sometimes referred to as mesenteric lymphoma, also referred to as non-Hodgkin's...

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

B cell lymphoma is not one disease but a few dozen heterogeneous diseases, or individual cancers, that affect the b...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Also known as Hodgkin's disease, Hodgkin's lymphoma (HL) is a cancer of the white blood cells, or...

Canine lymphoma, just like lymphoma in humans, can be separated into stages,...

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

It's not uncommon for patients with some lymphomas to experience itching (clinically known as pruritus). Lymphoma itching symptoms can range from...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...